DK146940C - Fremgangsmaade til fremstilling af sulfid-, sulfoxid- eller sulfonylderivater af clavulansyre - Google Patents

Fremgangsmaade til fremstilling af sulfid-, sulfoxid- eller sulfonylderivater af clavulansyre

Info

Publication number
DK146940C
DK146940C DK38577A DK38577A DK146940C DK 146940 C DK146940 C DK 146940C DK 38577 A DK38577 A DK 38577A DK 38577 A DK38577 A DK 38577A DK 146940 C DK146940 C DK 146940C
Authority
DK
Denmark
Prior art keywords
sulphoxide
sulphide
preparing
clavulanic acid
sulphonyl derivatives
Prior art date
Application number
DK38577A
Other languages
Danish (da)
English (en)
Other versions
DK146940B (da
DK38577A (da
Inventor
Roger John Ponsford
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3892/76A external-priority patent/GB1574906A/en
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Publication of DK38577A publication Critical patent/DK38577A/da
Publication of DK146940B publication Critical patent/DK146940B/da
Application granted granted Critical
Publication of DK146940C publication Critical patent/DK146940C/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D503/00Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
DK38577A 1976-01-31 1977-01-28 Fremgangsmaade til fremstilling af sulfid-, sulfoxid- eller sulfonylderivater af clavulansyre DK146940C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB3892/76A GB1574906A (en) 1976-01-31 1976-01-31 Therapeutic compounds containing - lactams
GB389276 1976-01-31
GB1900276 1976-05-08
GB1900276 1976-05-08

Publications (3)

Publication Number Publication Date
DK38577A DK38577A (da) 1977-08-01
DK146940B DK146940B (da) 1984-02-20
DK146940C true DK146940C (da) 1984-07-30

Family

ID=26238678

Family Applications (1)

Application Number Title Priority Date Filing Date
DK38577A DK146940C (da) 1976-01-31 1977-01-28 Fremgangsmaade til fremstilling af sulfid-, sulfoxid- eller sulfonylderivater af clavulansyre

Country Status (31)

Country Link
US (2) US4428958A (es)
JP (1) JPS5295689A (es)
AR (3) AR214306A1 (es)
AT (1) AT351675B (es)
AU (1) AU515736B2 (es)
BG (1) BG27751A3 (es)
CA (1) CA1089471A (es)
CH (2) CH637655A5 (es)
CS (1) CS196341B2 (es)
DD (1) DD128196A5 (es)
DE (1) DE2702954A1 (es)
DK (1) DK146940C (es)
ES (1) ES455404A1 (es)
FI (1) FI63581C (es)
FR (1) FR2339616A1 (es)
GR (1) GR62544B (es)
HK (1) HK69883A (es)
IE (1) IE44759B1 (es)
IL (1) IL51267A (es)
KE (1) KE3303A (es)
LU (1) LU76668A1 (es)
MX (1) MX4950E (es)
NL (1) NL7700892A (es)
NO (1) NO770279L (es)
NZ (1) NZ183117A (es)
PH (1) PH13924A (es)
PT (1) PT66071B (es)
RO (1) RO69712A (es)
SE (1) SE441359B (es)
SU (1) SU645583A3 (es)
YU (1) YU10777A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582884A (en) * 1977-05-19 1981-01-14 Beecham Group Ltd Clavulanic acid derivatives their preparation and use
GB2004541B (en) * 1977-09-16 1982-05-12 Beecham Group Ltd Ethers of clavulanic acid a process for their preparation and pharmaceutical compositions containing them
EP0008899B1 (en) * 1978-09-05 1982-09-15 Beecham Group Plc Clavulanic acid derivatives, their preparation and pharmaceutical compositions containing them
EP0018203B1 (en) * 1979-04-21 1983-03-02 Beecham Group Plc Clavulanic acid derivatives, their preparation and use in pharmaceutical compositions
IL60056A0 (en) * 1979-05-17 1980-07-31 Beecham Group Ltd Clavulanic acid derivatives,their preparation and pharmaceutical compositions containing them
DK330880A (da) * 1979-08-03 1981-02-04 Beecham Group Ltd Fremgangsmaade til fremstilling af clavulansyrederivater
NZ199061A (en) * 1980-12-09 1984-10-19 Beecham Group Ltd 9-(n-tetrazolyl)-deoxyclavulanic acids,salts,esters,and pharmaceutical compositions
NZ199200A (en) * 1980-12-23 1984-07-31 Beecham Group Ltd Clavulanic acid derivatives and pharmaceutical compositions
GB9518917D0 (en) * 1995-09-15 1995-11-15 Smithkline Beecham Plc Compounds
US5958462A (en) * 1997-05-23 1999-09-28 Mclean; Linsey Therapeutic bath salts and method of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4039673A (en) 1973-10-30 1977-08-02 Bayer Aktiengesellschaft Penicillins and cephalosporins and their production
US3983113A (en) 1975-08-15 1976-09-28 Syntex (U.S.A.) Inc. Cephalosporin type antibacterials

Also Published As

Publication number Publication date
US4505894A (en) 1985-03-19
ES455404A1 (es) 1978-05-01
CH637655A5 (de) 1983-08-15
SE441359B (sv) 1985-09-30
GR62544B (en) 1979-05-07
DK146940B (da) 1984-02-20
CS196341B2 (en) 1980-03-31
SE7700946L (sv) 1977-08-01
AU515736B2 (en) 1981-04-30
DD128196A5 (de) 1977-11-02
CH638529A5 (de) 1983-09-30
SU645583A3 (ru) 1979-01-30
NO770279L (no) 1977-08-02
IL51267A0 (en) 1977-03-31
AU2177077A (en) 1978-08-03
PT66071B (en) 1978-06-23
AT351675B (de) 1979-08-10
IE44759L (en) 1977-07-31
JPS613349B2 (es) 1986-01-31
KE3303A (en) 1983-08-05
FI770295A (es) 1977-08-01
CA1089471A (en) 1980-11-11
AR216555A1 (es) 1979-12-28
AR216925A1 (es) 1980-02-15
RO69712A (fr) 1980-07-15
AR214306A1 (es) 1979-05-31
YU10777A (en) 1982-06-30
FI63581C (fi) 1983-07-11
FR2339616A1 (fr) 1977-08-26
IE44759B1 (en) 1982-03-24
HK69883A (en) 1983-12-23
FR2339616B1 (es) 1980-04-11
IL51267A (en) 1979-12-30
NZ183117A (en) 1979-10-25
MX4950E (es) 1983-01-12
LU76668A1 (es) 1977-06-28
DK38577A (da) 1977-08-01
NL7700892A (nl) 1977-08-02
ATA53477A (de) 1979-01-15
JPS5295689A (en) 1977-08-11
DE2702954A1 (de) 1977-08-04
PH13924A (en) 1980-11-04
US4428958A (en) 1984-01-31
BG27751A3 (en) 1979-12-12
PT66071A (en) 1977-02-01
FI63581B (fi) 1983-03-31

Similar Documents

Publication Publication Date Title
PL195997A1 (pl) Sposob wytwarzania nowych pochodnych karboksyalkiloacyloaminokwasow
DK492677A (da) Fremgangsmaade til fremstilling af substituerede benzam9der
DK129477A (da) Fremgangsmade til fremstilling af alkyloximderivater af 7-aminothiazolylacetamidocephalosporansyre
DK23677A (da) Fremgangsmade til fremstilling af oximderivater af 7-aminothiazolyl-acetamidocephalosporansyre
DK258078A (da) Fremgangsmaade til fremstilling af 7alfa-methoxy-7beta-(1,3-dithiethan-2-carboxamido) cephalosporansyre-derivater
DK286777A (da) Fremgangsmade til fremstilling af penicillansyrederivater
DK55477A (da) Fremgangsmade til fremstilling af derivater af 1,2-dithiol
DK146940C (da) Fremgangsmaade til fremstilling af sulfid-, sulfoxid- eller sulfonylderivater af clavulansyre
DK55677A (da) Fremgangsmade til fremstilling af derivater af 1,2-dithiol
DK187677A (da) Fremgangsmade til fremstilling af derivater af 11-desoxyprostandin f2.
DK12477A (da) Fremgangsmade til fremstilling af 7-aminothiazolylacetamidocephalosporansyrederivater
DK372177A (da) Fremgangsmaade til fremstilling af thiophenderivater
DK97877A (da) Fremgangsmade til fremstilling af urinstofderivater
DK369677A (da) Fremgangsmaade til fremstilling af oximderivater af 3-carbamoyloxymethyl-7-aminothiazolylacetamidocephalosponsyre
DK31578A (da) Fremgangsmaade til fremstilling af benzenderivater
PL198731A1 (pl) Sposob wytwarzania nowych pochodnych 1-hydroksy-3-alkilodwubenzo/b,d/piranu
DK28278A (da) Fremgangsmaade til fremstilling af ergotderivater
DK145378C (da) Fremgangsmaade til fremstilling af 2,1,3-thiadiazin-4-on-2,2-dioxid-derivater
DK235477A (da) Fremgangsmade til fremstilling af uracilderivater
DK86277A (da) Fremgangsmade til fremstilling af clavulamsyrederivater
DK44278A (da) Fremgangsmaade til fremstilling af thiophenderivater
DK87977A (da) Fremgangsmade til fremstilling af benzylestere
PL204551A1 (pl) Sposob wytwarzania nowych pochodnych kwasu benzoheterocykloglioksalowego
DK159784C (da) Fremgangsmaade til fremstilling af 3-brommethyl-3-cephem-sulfoxidderivater
DK262478A (da) Fremgangsmaade til fr&mstilling af 15-substituerede omega-pentanorprostaglandinderivater

Legal Events

Date Code Title Description
PBP Patent lapsed